Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × PM 01183 × Clear all

NCT03213301 2021-07-14

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma